Table 11 Results of a 26-week Trial of Liraglutide Injection Compared to Placebo in Adult Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment a 14.2 Glycemic Control Trial in Pediatric Patients Aged 10 Years and Older with Type 2 Diabetes Mellitus Liraglutide injection was evaluated in a 26-week, double-blind, randomized, parallel group, placebo controlled multicenter trial (NCT01541215), in 134 pediatric patients with type 2 diabetes mellitus aged 10 years and older
Bookmark this section for quick reference
Fatty15 is the first and only supplement that contains the pure, vegan-friendly version of C15:0
Tel2 regulates redifferentiation of bipotential progenitor cells via Hhex during zebrafish liver regeneration
Okuno, S., Sato, H., Kuriyama-Matsumura, K., Tamba, M., Wang, H., Sohda, S